The Impact of Antiretroviral Therapy on Electrocardiographic Parameters in Human Immundeficiency Virus-Positive Patients
- PMID: 40131372
- PMCID: PMC11935195
- DOI: 10.1111/anec.70058
The Impact of Antiretroviral Therapy on Electrocardiographic Parameters in Human Immundeficiency Virus-Positive Patients
Abstract
Background: Antiretroviral therapy (ART) has revolutionized the management of human immunodeficiency virus (HIV) infection by transforming it into a chronic but manageable condition. Despite its effectiveness in viral suppression and immune restoration, concerns remain regarding ART's potential impact on cardiovascular health, particularly on electrocardiographic (ECG) parameters.
Objective: This study investigated the effects of ART on ECG parameters in HIV-infected patients by analyzing pre- and post-therapy data.
Methods: A total of 83 HIV-positive patients were enrolled and evaluated for ECG parameters before and 3 months after ART initiation. Key parameters, including QRS duration, QT duration corrected by the Bazett formula (QTc interval), QRS-T angle, morphology in inferior leads, voltage in lead 1, and P-wave duration (MVP) score, were manually assessed. Statistical analyses compared pre- and post-ART values.
Results: No statistically significant changes were observed in ECG parameters post-ART. For example, QRS duration remained stable (pre-ART: 89.08 ± 12.01 ms; post-ART: 88.94 ± 10.00 ms, p = 0.849), as did QTc interval (pre-ART: 403.51 ± 22.22 ms; post-ART: 404.84 ± 14.91 ms, p = 0.563) and MVP ECG score (pre-ART: 3.02 ± 0.95; post-ART: 2.98 ± 0.87, p = 0.882). The QRS-T angle also showed no significant difference (p = 0.675).
Conclusion: ART does not appear to significantly affect ECG parameters in HIV-infected patients, supporting its favorable cardiac safety profile. These findings highlight the importance of regular ECG monitoring to ensure cardiovascular safety in patients undergoing ART.
Keywords: antiretroviral therapy; electrocardiogram; human immundeficiency virus.
© 2025 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study).Am J Cardiol. 2013 Jan 1;111(1):118-24. doi: 10.1016/j.amjcard.2012.08.054. Epub 2012 Oct 9. Am J Cardiol. 2013. PMID: 23062314 Free PMC article. Clinical Trial.
-
QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.Ann Noninvasive Electrocardiol. 2014 Nov;19(6):561-6. doi: 10.1111/anec.12162. Epub 2014 Apr 21. Ann Noninvasive Electrocardiol. 2014. PMID: 24750179 Free PMC article.
-
Evaluation of Tp-e interval and Tp-e: QT and Tp-e: QTc ratios in patients infected with HIV and using antiretroviral therapy.Turk Kardiyol Dern Ars. 2021 Mar;49(2):135-142. doi: 10.5543/tkda.2021.76656. Turk Kardiyol Dern Ars. 2021. PMID: 33709919
-
QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs.Ann Afr Med. 2015 Oct-Dec;14(4):169-76. doi: 10.4103/1596-3519.152072. Ann Afr Med. 2015. PMID: 26470741
-
Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening.J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219833926. doi: 10.1177/2325958219833926. J Int Assoc Provid AIDS Care. 2019. PMID: 30907255 Free PMC article.
References
-
- Alexander, B. , MacHaalany J., Lam B., et al. 2017. “Comparison of the Extent of Coronary Artery Disease in Patients With Versus Without Interatrial Block and Implications for New‐Onset Atrial Fibrillation.” American Journal of Cardiology 119, no. 8: 1162–1165. - PubMed
-
- Barbara, T. , Olender S., Wilkin T. J., and SM H.. 2016. “Advances in Antiretroviral Therapy.” Topics in Antiviral Medicine 19, no. 2: 58–68. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous